If you enjoy “The Biggest Loser” or other reality shows in that vein, and you have diabetes, you’re gonna love this!!
Several years in the making, the TCOYD “Extreme Diabetes Makeover” program is underway now; episodes will start airing in May on TCOYD.org and its own TV channel, on YouTube, and at RealAge.com, the popular consumer health website run by Dr. Mehmet Oz of Oprah fame and his colleague Dr. Michael Roizen.
Wonder what I’m…
Read more »
Actually, we have Veenu Aulakh to thank for putting the DiabetesMine Design Challenge on the map. She heard me give a keynote speech at the Robert Wood Johnson Foundation’s Project HealthDesign event a few years ago, calling for more patient involved in medical device design, and it seems that a light bulb went on: the California HealthCare Foundation strives to foster better tools for patient self-management of chronic illnesses, so why not support a Crowdsourcing…
Read more »
Novo Nordisk is well-known in the diabetes community for its insulins, Novolog and Levemir, used to treat mainly type 1 diabetes. But in the last year, Novo launched a new kind of injectable, a “first line of defense for people with type 2 diabetes” called Victoza (generic: liraglutide). It’s a glucagon-like peptide-1 (GLP-1) drug designed to stimulate insulin secretion when hyperglycemia (high blood sugar) is present.
Victoza is still the new kid on the block…
Read more »
Richard Vaughn is a bit of a legend in the diabetes online community. Known more widely as Richard157 on several diabetes forums, Richard began sharing his story of living with type 1 diabetes for over 60 years via forum posts in 2007 and has become an inspiration for many. Last week, Richard also became a self-published author, releasing his memoirs, Beating The Odds: 64 Years of Diabetes Health, on Amazon.com.
Born in 1939 in rural…
Read more »
The high-powered diabetic cycling group Team Type 1 has once again pulled off a jaw-dropping feat: they’ve somehow caught the attention of 23andMe, one of just three celeb-status companies in the world offering “personal genomics services” — they scan people’s DNA for details on their ancestry and individual health risks — and convinced them to launch a probe into Type 1 and Type 2 diabetes.
This research could provide unprecedented insights into the genes that…
Read more »
